stella
beta
Type 2 DIAbeTes With NAFLD: innOvative Biomarkers of Disease progressioN and clInical outComes — Stella
Home
/
Metabolic Dysfunction-Associated Liver Disease
/
Type 2 DIAbeTes With NAFLD: innOvative Biomarkers of Disease progressioN and clInical outComes
View on ClinicalTrials.gov
Recruiting
Back to Metabolic Dysfunction-Associated Liver Disease trials
Type 2 DIAbeTes With NAFLD: innOvative Biomarkers of Disease progressioN and clInical outComes
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(4 sites)
France
Service Endocrinologie, Diabétologie, Maladies Métaboliques et Nutrition, Dijon
Endocrinologie, Diabète et Nutrition in Louis PRADEL Hospital, Lyon
Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition CIC Endocrino-Nut, Nantes
Service d'Endocrinologie, Diabète et nutrition, Pierre-Bénite